Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluating the efficacy of a multistrain probiotic supplementation for prevention of neonatal sepsis in 0-2-month-old low birth weight infants in India-the "ProSPoNS" Study protocol for a phase III, multicentric, randomized, double-blind, placebo-controlled trial.
Sinha AP, Gupta SS, Poluru R, Raut AV, Arora NK, Pandey RM, Sahu AR, Bethou A, Sazawal S, Parida S, Bavdekar A, Saili A, Gaind R, Kapil A, Garg BS, Maliye C, Jain M, Mahajan KS, Dhingra P, Pradhan KC, Kawade AS, Nangia S, Mukherjee A, Rasaily R, Sharma RS; ProSPoNS study Group. Sinha AP, et al. Among authors: mahajan ks. Trials. 2021 Apr 1;22(1):242. doi: 10.1186/s13063-021-05193-w. Trials. 2021. PMID: 33794969 Free PMC article.
Safety and Immunogenicity of SARS-CoV-2 Recombinant Spike Protein Vaccine in Children and Adolescents in India: A Phase 2-3 Randomized Clinical Trial.
Gunale B, Kapse D, Kar S, Bavdekar A, Kohli S, Lalwani S, Meshram S, Raut A, Kulkarni P, Samuel C, Munshi R, Gupta M, Plested JS, Cloney-Clark S, Zhu M, Pryor M, Hamilton S, Thakar M, Shete A, Dharmadhikari A, Bhamare C, Shaligram U, Poonawalla CS, Mallory RM, Glenn GM, Kulkarni PS; COVOVAX-Ped study group. Gunale B, et al. JAMA Pediatr. 2023 Jul 31;177(9):911-20. doi: 10.1001/jamapediatrics.2023.2552. Online ahead of print. JAMA Pediatr. 2023. PMID: 37523166 Free PMC article.
Role of central endpoint adjudication and challenges in trials on neonatal sepsis-a case of ProSPoNS trial.
Sinha AP, Raja D, Mahajan KS, Sharma P, Gupta SS, Poluru R, Kawade AS, Dayma G, Sazawal S, Bavdekar A, Parida S, Nangia S, Raut AV, Bethou A, Devi P, Gorpade M, Fatima T, Nayak R, Kapil A, Azam M, Khan PA, Pandey RM, Arora NK; ProSPoNS Study Group. Sinha AP, et al. Among authors: mahajan ks. Trials. 2024 Jul 5;25(1):458. doi: 10.1186/s13063-024-08298-0. Trials. 2024. PMID: 38970042 Free PMC article.
Study protocol for economic evaluation of probiotic intervention for prevention of neonatal sepsis in 0-2-month old low-birth weight infants in India: the ProSPoNS trial.
Sinha A, Bahuguna P, Gupta SS, Kuruba YP, Poluru R, Mathur A, Raja D, Raut AV, Mahajan KS, Sudhakar R, Kulkarni B, Pandey RM, Arora NK, Prinja S. Sinha A, et al. Among authors: mahajan ks. BMJ Open. 2023 Mar 29;13(3):e068215. doi: 10.1136/bmjopen-2022-068215. BMJ Open. 2023. PMID: 36990484 Free PMC article.
12 results